biocon final

8/7/2019 Biocon final

1/21

KIRAN MAZUMDAR SHAW

THE BIOCON STORY


2/21

Biocon Info.y Company's Slogan: Driving Innovation Delivering

Affordability

y

Company's Mission: To be an integrated biotechnologyenterprise of global distinction.

y Company Type: Private Sector

y Industry: Pharmaceuticals

y

Number of Employees -4478


3/21

Dr. Kiran M. Shaw

Born on23 March

1953 inBangalor

e

B.ScZoology

fromBangalor

euniversity

1973

Masterbrewerfrom

BallaratUniversity

inMelbourne

1975

Traineebrewer inCarlton &

UnitedBeveragesin 1975-77

FirstIndianwoman

brewmaster

JoinedBiocon

biochemical Ltd.

Ireland in1978

Dr. KiranM. Shaw

In 1978foundedBioconIndia


4/21

The journey beginsy Started Biocon India from her garage.

y Initial Capital Rs/- 10,000.

y Started extracting enzyme (papain) from papaya &isinglass (fish moss)


5/21

Early Hurdlesy Financing regular operations

y Approached financial institutions, but turned down,

coz:y Biotechnology is a new word

y No assets for company

y Woman entrepreneur is a rare word

y

Recruiting staff


6/21

Break through..y 1979 -Biocon is the first Indian company to manufacture

and export enzymes to USA and Europe

y 19 9-Unilever plc. acquires Biocon Biochemicals Ltd. inIreland and merges it with its subsidiary, QuestInternational

y Biocon is the first Indian biotech company to receive USfunding for proprietary technologies

y

1990 Biocon scales up its in-house research programme,based on a proprietary solid substrate fermentationtechnology, from pilot to plant level

y 1993 Biocon's R&D and manufacturing facilities receive ISO9001 certification from RWTUV, Germany


7/21

Cont..y 1994 Biocon establishes Syngene International Pvt. Ltd. as a

Custom research Company (CRC) to address the growing needfor outsourced R&D in the pharmaceutical sector.Its India's first

custom research company in drug discovery.y 1997 Biocon spearheads initiatives in human healthcare througha dedicated manufacturing facility

y 199 Unilever inks a deal with ICI to sell its specialty chemicalsdivision of which Quest International is a part. Unilever agreesto sell its shareholding in Biocon to the Indian promoters.

Biocon becomes an independent entityy 2000 Biocon commissions its first fully automated submerged

fermentation plant to produce specialty pharmaceuticals.Bioconestablishes Clinigene, India's first Clinical ResearchOrganisation (CRO) to pursue clinical research anddevelopment


8/21

Cont..y 2001 Biocon becomes the first Indian company to be approved by USFDA for the manufacture of lovastatin, a cholesterol-lowering moleculeBiocon's proprietary bioreactor, PlaFractor is granted a US 2001 andworld-wide patent

y 2002 Clinigene's clinical laboratory is the first in India to receive CAPaccreditation

y 2003 Biocon is the first company worldwide to develop human insulinon a Pichia expression system

y 2004 Biocon creates a buzz in the stock market in March 2004 with itshugely successful IPO. Day 1 on the bourses closes with a market valueof $1.11 billion, making Biocon only the second Indian company to crossthe $1 billion mark on the first day of listing.Biocon Limited announces the launch of INSUGENR, the newgeneration bio-insulin , manufactured in Asia's largest human insulinplant.


9/21


10/21

Cont..y 2006 Biocon inaugurates Biocon Biopharmaceuticals, India's

largest multi-product Biologics facility at Biocon ParkBiocon launches India's first anti-cancer drug BIOMAb EGFR.

y 2007 Biocon and Abu Dhabi based pharmaceutical companyNeopharma sign an MOU to establish a JV to manufacture andmarket a range of biopharmaceuticals for the GCC countries(Gulf Cooperation Council). .

y Biocon announces the launch of its Nephrology Division and acomprehensive portfolio of renal therapy products.

y 200 Biocon acquires a 70% stake in German pharmaceuticalcompany, AxiCorp GmbH for a consideration of 30 MillionBiocon and Abraxis Bioscience launch ABRAXANE in India for

treatment of Breast Cancer.


11/21

Cont..y Biocon is ranked among the top 20 global

biotechnology companies (Med Ad News). Biocon is

the 7th largest biotech employer in the world (Med AdNews).


12/21

The process


13/21

Products and servicesBiopharmaceuticals icensing Contract manufacturing Research

services

Anti-Diabetic Agents Anti-Hypertensive Agents Anti-Inflammatory Agents Antioxidants Cardiovascular Agents

Digestive Aid Enzymes Haemostatic Agents Hepatoprotective Agents Immunosuppressants Nutraceuticals


14/21

Financials


15/21

Strategies

y No commodity production in beginning due to lack of infrastructurey Diversification rather than expansiony Formed Helix (antibiotic prod.)y Formed Syngene, Clinigene (R&D in fermentation)y Biocon Quest (BQ) to produce these products in massy Strategic alliances with 20 companies around globe. Eg AXICORP , DEAKIN

UNIVERSITYy Fully integrated business modely Enzymes produced & sold as industrial intermediariesy

Customer (staying with buyers processing line helping them obtain desiredresult from the enzyme)y Created an image of a reliable company able to give highly competent technical

products & supporty Also custom based products at any level.


16/21

Competitors..y Cadila Healthcare

y Divi's Lab

y

Lupin Ltd.y Glenmark Pharma

y GlaxoSmithKline Phar

y Aurobindo Pharma

y Dr. Reddy's Labsy Fortis Healthcare

y Sun Pharma.

y Cipla (Sensex)


17/21

Future & long term developmentsy Mega-marketing deal with

Pfizer to drive growth in theshort term:In October, 2010,

Biocon signed a mega-marketingdeal with the worlds largestPharma company.

y Focus on emerging countries

y Oral insulin the next

blockbuster opportunity


18/21

CSR- Biocon

Foun

dation

y Arogya Raksha Yojana (ARY) Healthcare Initiatives

y Primary Health Education & Implementation

y Infrastructure: constructing school buildings(including a performance stage, ooring,classrooms),creches, sanitary facilities and watersupply connections.

Under phase I of the sanitation program, 700 toiletshave been built in Huskur.


19/21

Recognition:y Kiran Mazumdar-Shaw features on the Forbes list of The

Worlds 100 Most Powerful Womeny Awarded the prestigious Nikkei Asia Prize 2009 for regional

growth.y Padma Bhushan (2005)y The Economic Times Business Woman of the Year Award (2004)y Ernst & Young Entrepreneur of the Year Award in Healthcare &

Life Sciences (2002) Padma Shri (1989)y Outstanding Young Person Award by Jaycees (1987) Rotary

award for the Best Model Employer (1983)y Gold for Best Woman Entrepreneur , Institute of Marketing

Management (1982)


20/21

SUCCESS MANTRA MS. SHAWy Determination

y Willingness to take risk

y Talented teamy Spirit of Adventure


21/21

Thank you.

biocon final

Documents